Acadia Healthcare Company (ACHC) Heads To Jefferies Conference, Is A 15% Undervaluation Still Intact?
Acadia Healthcare Company (ACHC) is on investor radars ahead of its presentation at the 2026 Jefferies Healthcare Services and Technology Conference in Nashville on September 14, a forum closely watched by healthcare-focused portfolios.
Recent trading in Acadia Healthcare Company has cooled off, with a 30-day share price return down 11.19% after a strong 90-day gain of 16.51% and a year-to-date share price surge of 91.60%. The 1-year total shareholder return of 26.12% still sits against a much weaker 3-year and 5-year total shareholder return, where long-term holders have seen declines of 60.78% and 57.04%. This pattern hints that enthusiasm has built quickly off a low base as investors look to events like the Jefferies conference for clues on whether this newer momentum can hold.
Scan beyond Acadia Healthcare Company and line up other potential rebound stories using our hand picked 16 high quality undiscovered gems tailored for investors tracking fresh momentum following difficult multi year returns.
Bulls point to Acadia Healthcare Company’s sharp rebound and analyst upside, while bears focus on multi year losses and the recent share pullback. Which side does the current valuation actually support next?
Most Popular Narrative: 15% Undervalued
On Simply Wall St's most followed narrative, Acadia Healthcare Company screens as undervalued, with a fair value of $32.21 against a last close of $27.38. This view places significant emphasis on the execution of its growth and turnaround plans.
Accelerated facility development, including opening beds ahead of schedule, joint ventures with large healthcare systems, and ongoing expansion in high-demand lines (comprehensive treatment centers, specialty care), is expected to support multiyear growth in revenue and operational efficiency as new facilities ramp up.
See why 2 investors see Acadia Healthcare Company as 15% undervalued.
Result: Fair Value of $32.21 (UNDERVALUED)
Still, the narrative around Acadia Healthcare Company can crack if Medicaid reimbursement tightens further, or if ongoing legal costs keep dragging on profitability and cash generation.
Find out about the key risks to this Acadia Healthcare Company narrative.
Next Steps
Mixed messages in the Acadia Healthcare Company story make it even more important to look at the underlying data yourself and move quickly while the narrative is still forming. To weigh both the concerns and the potential upside in one place, start with the 3 key rewards and 1 important warning sign.
Looking for more Acadia Healthcare investment ideas?
Do not stop with Acadia Healthcare Company when a wider set of opportunities is only a few clicks away on the Simply Wall St screener.
- Target resilient balance sheets by scanning our list of solid balance sheet and fundamentals (22 results) that prioritise financial strength and cleaner fundamentals when markets turn choppy.
- Zero in on quality for price with the 34 high quality undervalued stocks filtered to highlight companies where fundamentals and valuation screens line up.
- Dial back risk a notch and focus on steadier profiles using the 11 resilient stocks with low risk scores that can help anchor a more balanced portfolio.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com